Guangzhou Trauer Biotechnology Co., Ltd.
As a Leading China Medical Collagen Raw Material Supplier, Trauer Biotech Presents Triple-Helix Atelocollagen Mechanisms for Skin Repair at Prestigious GRC Conference-
As a Leading China Medical Collagen Raw Material Supplier, Trauer Biotech Presents Triple-Helix Atelocollagen Mechanisms for Skin Repair at Prestigious GRC Conference
2025-08-05
Recently, Dr. Ye Chunting, co-founder and Chief Scientist of Trauer Biotechnology, led a delegation to the United States to participate in the Gordon Research Conferences (GRC), a globally influential academic event. The GRC serves as a premier pla...
Good News | Trauer Biotech. Completed FDA MAF Filing, Making Another Step to Globalization-
Good News | Trauer Biotech. Completed FDA MAF Filing, Making Another Step to Globalization
2024-08-19
Milestone Moment : MAF Submission Officially Receiv ed Recently, Guangzhou Trauer Biotechnology Co., Ltd. (hereinafter referred to as “Trauer ”) completed the filing of M aster F iles for Devices (MAFs) with the U.S. Food and Drug Adminis...
Hand in Hand with Global Leaders in Collagen | Inauguration of Trauer Biotech.’s International R&D Center Concludes Successfully-
Hand in Hand with Global Leaders in Collagen | Inauguration of Trauer Biotech.’s International R&D Center Concludes Successfully
2025-09-23
Recently, Guangzhou Trauer Biotechnology Co ., Ltd. (hereinafter referred to as “Trauer” ) held the inauguration ceremony for its International Research & Development Center in San Francisco, U . S. Renowned for openness, diversity, and innovatio...
Trauer Bio & Belt and Road Lab Launch 3-Yr Collagen Skin Health Collaboration-
Trauer Bio & Belt and Road Lab Launch 3-Yr Collagen Skin Health Collaboration
2024-11-12
On November 12th, Academician Liao Wanqing of the Chinese Academy of Engineering and Director of the " the Belt and Road" International Joint Laboratory for Fungal Diseases, accompanied by Dr. Du Mingwei, visited Guangzhou Trau er . The two parties ...
Trauer Biotechnology's porcine type I atelocollagen raw material completes the registration of the NMPA medical device raw material master file!-
Trauer Biotechnology's porcine type I atelocollagen raw material completes the registration of the NMPA medical device raw material master file!
2024-08-19
On 10 August 2024, the NMPA Technical Review Centre published the latest Master File Registration Information. Trauer Biotechnology's medical porcine triple helix type I atelocollagen raw material has successfully passed the Master File Registration...
New Product Launch | Endotoxin <0.02EU/mg Collagen Sponge S-
New Product Launch | Endotoxin <0.02EU/mg Collagen Sponge S
2024-07-19
Trauer Biotechnology introduces a medical-grade low endotoxin (<0.02EU/mg) collagen sponge to the global medical field.